Northwell Health’s Cohen Children’s Medical Center became the first hospital in New York State to administer Lyfgenia to a patient — a lifechanging genetic therapy for sickle cell disease. Sickle cell ...

The iTind is a minimally invasive temporary device designed to relieve LUTS secondary to BPH. This study is designed to compare the minimally invasive iTind device to the UroLift System.

The purpose of this trial is to evaluate the effectiveness and safety of the HistoSonics Edison System for the destruction of kidney tissue by treating primary solid renal tumors. This is a ...